VFY Vitrafy Life Sciences Ltd.

ASX · AU · Healthcare · Life Science Tools · vitrafy.com

—Mkt Cap: —P/E: —Today

Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. It offers cryopreservation medical devices, including freezers, thawers, and packaging…

Key Statistics

Company

Market Cap—

Enterprise Value121.25M USD

Revenue (TTM)144.43K USD

Gross Profit116.60K USD

Net Income (TTM)-11.18M USD

Revenue/Share0.0030 AUD

Last Price—

Fiscal Year EndJun 2026

MR QuarterJun 2026

Employees—

CountryAU

SectorHealthcare

IndustryLife Science Tools

ISINAU0000361297

Valuation

P/E (Trailing)—

P/E (Forward)-10.64

PEG—

EV/EBITDA-10.49

EV/Revenue839.45

P/S1028.72

P/B5.17

EPS (TTM)-0.25

EPS (Forward)-0.27

52W Range

—

52W High—

52W Low—

Profitability

Gross Margin100.00%

Oper. Margin522.50%

EBITDA Margin0.00%

Profit Margin-9584.18%

ROE-39.34%

ROA-37.42%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-10.90M USD

CapEx (TTM)371.36K USD

FCF Margin-5184.87%

FCF Yield—

Net Debt-28.28M USD

Net Debt/EBITDA2.45

Balance Sheet

Debt/Equity0.01

Current Ratio23.77

Quick Ratio23.77

Book Value/Sh0.55 AUD

Cash/Share0.55 AUD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 AUD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)5.135 AUD

Target Range5.099 AUD – 5.207 AUD

# Analysts3

Ownership

Shares Out.76.24M

Float50.62M

Insiders45.14%

Institutions2.27%

Technical

SMA 503.691 AUD

SMA 2002.633 AUD

Beta—

S&P 52W Chg16.44%

Avg Vol (30d)—

Avg Vol (10d)45.30K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

VFY Vitrafy Life Sciences Ltd.

Industry Peers

Key Statistics